Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.09M Buy
290,000
+140,000
+93% +$2.49M ﹤0.01% 3919
2026
Q2
$2.44M Buy
+150,000
New +$2.67M ﹤0.01% 4932
2024
Q2
– Sell
-68,600
Closed -$1.76M – 10188
2024
Q1
$1.76M Buy
+68,600
New +$1.72M ﹤0.01% 4075
2022
Q1
– Sell
-45,360
Closed -$1.3M – 10989
2021
Q4
$1.3M Buy
+45,360
New +$1.48M ﹤0.01% 4155
2021
Q2
– Sell
-433,739
Closed -$16.3M – 9885
2021
Q1
$16.3M Buy
+433,739
New +$18.5M 0.01% 1577

Other funds holding XP

UBS Group's XP Position: Q3 2026 in Review

UBS Group reduced its XP (XP) stake by 33% in Q3 2026, selling an estimated $10M and leaving 1,163,832 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

UBS Group first reported a position in XP in Q4 2019 and has held it in 28 quarters since. The position peaked at $28.1M in Q1 2026. 182 funds tracked by Wall St. Rank hold XP as of Q3 2026.

  • UBS Group held 1,163,832 shares of XP worth $24.4M as of Q3 2026.
  • UBS Group sold 560,971 XP shares in Q3 2026, an estimated $10M.
  • XP made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2451 holding.
  • UBS Group first reported a position in XP in Q4 2019 and has held it in 28 quarters since.
  • UBS Group's XP position peaked at $28.1M in Q1 2026.
  • 182 funds tracked by Wall St. Rank held XP as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.